KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Supernus Pharmaceuticals (SUPN) Amortization - Intangibles (2019 - 2025)

Historic Amortization - Intangibles for Supernus Pharmaceuticals (SUPN) over the last 7 years, with Q3 2025 value amounting to $24.3 million.

  • Supernus Pharmaceuticals' Amortization - Intangibles rose 2474.36% to $24.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $83.2 million, marking a year-over-year increase of 294.7%. This contributed to the annual value of $78.0 million for FY2024, which is 533.98% down from last year.
  • Latest data reveals that Supernus Pharmaceuticals reported Amortization - Intangibles of $24.3 million as of Q3 2025, which was up 2474.36% from $20.8 million recorded in Q2 2025.
  • Supernus Pharmaceuticals' 5-year Amortization - Intangibles high stood at $24.3 million for Q3 2025, and its period low was $5.9 million during Q2 2021.
  • For the 5-year period, Supernus Pharmaceuticals' Amortization - Intangibles averaged around $17.8 million, with its median value being $20.1 million (2023).
  • Its Amortization - Intangibles has fluctuated over the past 5 years, first soared by 36207.69% in 2021, then plummeted by 1336.08% in 2024.
  • Quarter analysis of 5 years shows Supernus Pharmaceuticals' Amortization - Intangibles stood at $12.0 million in 2021, then skyrocketed by 71.97% to $20.7 million in 2022, then grew by 1.86% to $21.1 million in 2023, then fell by 13.36% to $18.3 million in 2024, then skyrocketed by 33.16% to $24.3 million in 2025.
  • Its Amortization - Intangibles was $24.3 million in Q3 2025, compared to $20.8 million in Q2 2025 and $19.8 million in Q1 2025.